These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37727880)

  • 1. Anti-prolactin treatment alleviates lupus conditions by regulating the JAK2-STAT3 pathway.
    Jiang Y; Chen H; Lin J; Pan J; Shen Y; Li Q
    Clin Exp Pharmacol Physiol; 2023 Dec; 50(12):936-943. PubMed ID: 37727880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.
    Rohraff DM; He Y; Farkash EA; Schonfeld M; Tsou PS; Sawalha AH
    Arthritis Rheumatol; 2019 Oct; 71(10):1681-1690. PubMed ID: 31106974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
    Lu LD; Stump KL; Wallace NH; Dobrzanski P; Serdikoff C; Gingrich DE; Dugan BJ; Angeles TS; Albom MS; Mason JL; Ator MA; Dorsey BD; Ruggeri BA; Seavey MM
    J Immunol; 2011 Oct; 187(7):3840-53. PubMed ID: 21880982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L; Chen HP; Ma Q
    Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
    Wu Y; He S; Bai B; Zhang L; Xue L; Lin Z; Yang X; Zhu F; He P; Tang W; Zuo J
    Cell Mol Immunol; 2016 May; 13(3):379-90. PubMed ID: 25942599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
    Yang J; Li Q; Yang X; Li M
    Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin levels correlate with abnormal B cell maturation in MRL and MRL/lpr mouse models of systemic lupus erythematosus-like disease.
    Legorreta-Haquet MV; Flores-Fernández R; Blanco-Favela F; Fuentes-Pananá EM; Chávez-Sánchez L; Hernández-González R; Tesoro-Cruz E; Arriaga-Pizano L; Chávez-Rueda AK
    Clin Dev Immunol; 2013; 2013():287469. PubMed ID: 24454471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway.
    Chen XC; Wu D; Wu HL; Li HY; Yang C; Su HY; Liu ZJ; Huang XR; Lu X; Huang LF; Zhu SP; Pan QJ; An N; Liu HF
    Lupus Sci Med; 2022 Apr; 9(1):. PubMed ID: 35414608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
    Jiang C; Zhao ML; Scearce RM; Diaz M
    Arthritis Rheum; 2011 Apr; 63(4):1086-96. PubMed ID: 21225690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin Rescues Immature B Cells from Apoptosis-Induced BCR-Aggregation through STAT3, Bcl2a1a, Bcl2l2, and Birc5 in Lupus-Prone MRL/lpr Mice.
    Flores-Fernández R; Aponte-López A; Suárez-Arriaga MC; Gorocica-Rosete P; Pizaña-Venegas A; Chávez-Sanchéz L; Blanco-Favela F; Fuentes-Pananá EM; Chávez-Rueda AK
    Cells; 2021 Feb; 10(2):. PubMed ID: 33557010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
    Su B; Ye H; You X; Ni H; Chen X; Li L
    Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 inhibition ameliorates renal interstitial inflammation in MRL/lpr mice with diffuse proliferative lupus nephritis.
    Zhu J; Chen Y; Chen Y; Lv Y; Chen T
    Ren Fail; 2024 Dec; 46(1):2358187. PubMed ID: 38803234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-
    Wada Y; Gonzalez-Sanchez HM; Weinmann-Menke J; Iwata Y; Ajay AK; Meineck M; Kelley VR
    J Am Soc Nephrol; 2019 Feb; 30(2):244-259. PubMed ID: 30622154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan.
    Keil A; Hall SR; Körner M; Herrmann M; Schmid RA; Frese S
    Arthritis Res Ther; 2016 Oct; 18(1):243. PubMed ID: 27770825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice.
    Edwards LJ; Mizui M; Kyttaris V
    Clin Immunol; 2015 Jun; 158(2):221-30. PubMed ID: 25869298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice.
    Zhang X; Wang G; Bi Y; Jiang Z; Wang X
    Int Immunopharmacol; 2022 Nov; 112():109133. PubMed ID: 36113317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
    He J; Sun M; Tian S
    Innate Immun; 2018 Jul; 24(5):307-315. PubMed ID: 29874961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S3I-201 ameliorates tubulointerstitial lesion of the kidneys in MRL/lpr mice.
    Du Y; Zhang W; Liu S; Feng X; Gao F; Liu Q
    Biochem Biophys Res Commun; 2018 Sep; 503(1):177-180. PubMed ID: 29885836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.